Exposure to light at night accelerates aging and spontaneous uterine carcinogenesis in female 129/Sv mice

Cell Cycle

Volumn 12, Issue 11, 2013, Pages 1785-1790

  Popovich, Irina G ^a   Zabezhinski, Mark A ^a   Panchenko, Andrei V ^a   Piskunova, Tatiana S ^a   Semenchenko, Anna V ^a   Tyndyk, Maragriata L ^a   Yurova, Maria N ^a   Anisimov, Vladimir N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

129 Sv mice; Lifespan; Light at night; Tumorigenesis

Indexed keywords

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; ILLUMINATION; LIGHT DARK CYCLE; LIGHT EXPOSURE; MOUSE; NIGHT; NONHUMAN; UTERINE CARCINOGENESIS; UTERUS CANCER; UTERUS TUMOR; WEIGHT GAIN;

MUS;

EID: 84878613973     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.24879     Document Type: Article

References (51)

1. Arendt J. Melatonin and the Mammalian Pineal Gland. London: Chapman & Hall, 1995.
2. Bell-Pedersen D, Cassone VM, Earnest DJ, Golden SS, Hardin PE, Thomas TL, et al. Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet 2005; 6:544-56; PMID:15951747; http://dx.doi.org/10. 1038/nrg1633
3. Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. Mol Med 2012; 18:1249-60; PMID:22811066; http://dx.doi.org/10.2119/ molmed. 2012.00077
4. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001; 93:1563-8; PMID:11604480; http://dx.doi.org/10.1093/jnci/93.20.1563
5. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Night-shifts work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003; 5:825-8; http://dx.doi.org/10.1093/jnci/95.11. 825
6. Hansen J, Lassen CF. Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med 2012; 69:551-6; PMID:22645325; http://dx.doi.org/10.1136/oemed-2011-100240
7. Stevens RG. Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol 2009; 38:963-70; PMID:19380369; http://dx.doi.org/10.1093/ije/dyp178
8. Kloog I, Haim A, Stevens RG, Portnov BA. Global co-distribution of light at night (LAN) and cancers of prostate, colon, and lung in men. Chronobiol Int 2009; 26:108-25; PMID:19142761; http://dx.doi. org/10.1080/07420520802694020
9. Kloog I, Stevens RG, Haim A, Portnov BA. Nighttime light level co-distributes with breast cancer incidence worldwide. Cancer Causes Control 2010; 21:2059-68; PMID:20680434; http://dx.doi.org/10.1007/s10552-010-9624-4
10. Bartsch C. Light-at-night, cancer and aging. Aging (Albany NY) 2010; 2:76-7; PMID:20354267
11. Vinogradova I, Anisimov V. Light Regimen, Pineal Preparations, Aging and Lifespan. Experimental Study. Saarbrucken: LAP LAMBERT Academic Publishing. 2012.
12. Dubrovsky YV, Samsa WE, Kondratov RV. Deficiency of circadian protein CLOCK reduces lifespan and increases age-related cataract development in mice. Aging (Albany NY) 2010; 2:936-44; PMID:21149897
13. Kondratova AA, Dubrovsky YV, Antoch MP, Kondratov RV. Circadian clock proteins control adaptation to novel environment and memory formation. Aging (Albany NY) 2010; 2:285-97; PMID:20519775
14. Brown SA, Schmitt K, Eckert A. Aging and circadian disruption: causes and effects. Aging (Albany NY) 2011; 3:813-7; PMID:21869460
15. Khapre RV, Kondratova AA, Susova O, Kondratov RV. Circadian clock protein BMAL1 regulates cellular senescence in vivo. Cell Cycle 2011; 10:4162-9; PMID:22101268; http://dx.doi.org/10.4161/cc.10.23.18381
16. Yu EA, Weaver DR. Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany NY) 2011; 3:479-93; PMID:21566258
17. Kondratova AA, Kondratov RV. The circadian clock and pathology of the ageing brain. Nat Rev Neurosci 2012; 13:325-35; PMID:22395806
18. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007; 8:1065-6; PMID:19271347; http://dx.doi.org/10.1016/S1470-2045(07)70373-X
19. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume Painting, Firefighting, and Shiftwork. Lyon: IARC. 2010.
20. Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, et al. Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med 2011; 68:154-62; PMID:20962033; http://dx.doi. org/10.1136/oem.2009.053512
21. Anisimov VN. The role of pineal gland in breast cancer development. Crit Rev Oncol Hematol 2003; 46:221-34; PMID:12791421; http://dx.doi.org/10.1016/ S1040-8428(03)00021-0
22. Anisimov VN. Light pollution, reproductive function and cancer risk. Neuro Endocrinol Lett 2006; 27:35-52; PMID:16648818
23. Bartsch C, Barstch H, Peschke E. Light, melatonin and cancer: current results and future perspectives. Biol Rhythm Res 2009; 40:17-35; http://dx.doi. org/10.1080/09291010802066983
24. Baturin DA, Alimova IN, Anisimov VN, Popovich IG, Zabezhinski MA, Provinciali M, et al. Effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuro Endocr Lett 2001; 22:439-45
25. Deerberg F, Bartsch C, Pohlmeyer G, Bartsch H. Effect of melatonin and phusiological epiphysectomy on the development of spontaneous endometrial carcinoma in BDII/Han rats. Cancer Biother Radiother 1997; 12:420
26. van den Heiligenberg S, Deprés-Brummer P, Barbason H, Claustrat B, Reynes M, Lévi F. The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sci 1999; 64:2523-34; PMID:10403512; http://dx.doi. org/10.1016/S0024-3205(99)00210-6
27. Beniashvili DS, Benjamin S, Baturin DA, Anisimov VN. Effect of light/dark regimen on N-nitrosoethylureainduced transplacental carcinogenesis in rats. Cancer Lett 2001; 163:51-7; PMID:11163108; http://dx.doi. org/10.1016/S0304- 3835(00)00673-X
28. Anisimov VN. Carcinogenesis and Aging, Vol Boca Raton, FL: CRC Press, Inc. 1987.
29. Prata Lima MF, Baracat EC, Simões MJ. Effects of melatonin on the ovarian response to pinealectomy or continuous light in female rats: similarity with polycystic ovary syndrome. Braz J Med Biol Res 2004; 37:987-95; PMID:15264005; http://dx.doi.org/10.1590/S0100-879X2004000700007
30. Lazarev NI, Ird EA, Smirnova IO. Experimental Models of Endocrine Gynecological Diseases. Moscow: Meditsina 1976.
31. Dilman VM, Anisimov VN. Hypothalmic mechanisms of ageing and of specific age pathology-I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system. Exp Gerontol 1979; 14:161-74; PMID:225186; http://dx.doi.org/10.1016/0531-5565(79)90015-9
32. Rossmanith WG. Neuroendocrinology of aging in the reproductive system, gonadotropin secretion as an example. In: Follicular Gowrth, Ovulation and Fertilization, Molecular and Clinical Basis. Kumar A, Mukhopadhayay AK, eds. New Dehly: Narosa Publ House: 15-25. 2001.
33. Vinogradova IA, Anisimov VN, Bukalev AV, Semenchenko AV, Zabezhinski MA. Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats. Aging (Albany NY) 2009; 1:855-65; PMID:20157558
34. Vinogradova IA. Effect of light regimen on metabolic syndrome development during the aging in rats. Adv Gerontol 2007; 20:70-5; PMID:18306692
35. Vinogradova I, Anisimov V. Light Regimen, Pineal Preparations, Aging and Lifespan. Experimental Study. Saarbrucken: LAP LAMBERT Academic Publishing. 2012.
36. Luchsinger JA. A work in progress: the metabolic syndrome. Sci Aging Knowledge Environ 2006; 2006:pe19; PMID:16807483; http://dx.doi. org/10.1126/sageke.2006.10.pe19
37. Dilman VM. Development, Aging and Disease. A New Rationale for an Intervention. Chur: Harwood Academic Publishers. 1994.
38. Anisimov VN. Metformin for aging and cancer prevention. Aging (Albany NY) 2010; 2:760-74; PMID:21084729
39. Panchenko AV, Petrischev NN, Kvetnoy IM, Anisimov VN. Colon carcinogenesis in rats maintained at various light regimens. Vopr Onkol 2008; 54:332-6; PMID:18652239
40. Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA. Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 2006; 1757:573-89; PMID:16678784; http://dx.doi.org/10. 1016/j.bbabio. 2006.03.012
41. Anisimov VN, Popovich IG, Zabezhinski MA. Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 1997; 18:1549-53; PMID:9276629; http://dx.doi.org/10.1093/carcin/18.8.1549
42. Blask DE. An overview on the neuroendocrine regulation of experimental tumor growth by melatonin and its analogues and the therapeutic use of melatonin in oncology. In: Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke D, eds. The Pineal Gland and Cancer. Neuroimmunoendocrine Mechanisms in Malignancy. Berlin: Springer, pp 309-342. 2001.
43. Leon-Blanco MM, Guerrero JM, Reiter RJ, Calvo JR, Pozo D. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res 2003; 35:204-11; PMID:12932205; http://dx.doi.org/10.1034/j. 1600-079X.2003.00077.x
44. Reiter RJ. Reactive oxygen species, DNA damage, and carcinogenesis: intervention with melatonin. In: Bartsch C, Bartsch H, Blask DE, Cardinali DP, Hrushesky WJM, Mecke D, eds. The Pineal Gland and Cancer. Neuroimmunoendocrine Mechanisms in Malignancy. Berlin: Springer, pp 442-455. 2001.
45. Sánchez-Barceló EJ, Cos S, Fernández R, Mediavilla MD. Melatonin and mammary cancer: a short review. Endocr Relat Cancer 2003; 10:153-9; PMID:12790777; http://dx.doi.org/10.1677/erc.0.0100153
46. Anisimov VN, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Manton KG, et al. The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int J Cancer 2003; 103:300-5; PMID:12471612; http://dx.doi.org/10.1002/ijc.10827
47. Anisimov VN, Popovich IG, Zabezhinski MA. Methods of evaluating the effect of pharmacological drugs on aging and lifespan in mice. Methods Mol Biol 2007; 371:227-36; PMID:17634585; http://dx.doi. org/10.1007/978-1-59745-361-5-17
48. Turusov VS, Mohr U, eds. Pathology of Tumours in Laboratory Animals. Vol. I. Tumours of the Mouse. 2nd ed. (IARC Sci. Publ. No 111). Lyon: IARC, 1994.
49. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman & Hall, 1996.
50. Taron RE. Tests for trend in life table analysis. Biometrika 1975; 62:679-82; http://dx.doi. org/10.1093/biomet/62.3.679
51. Gauss System and Graphic Manual. Maple Valley: Aptech Systems, Inc., 1994